USANA Health Sciences Stock Forecast for 2023 - 2025 - 2030

Updated on 02/05/2023

Stock Rating
14
Price Target
$57.00
Consensus
Neutral
Downside
-5.06%
Analysts
1
Stock Rating
14
Downside
-5.06%
Analysts
1
Price Target
$57.00

USANA Health Sciences Stock Forecast and Price Target

The average target price set lately by experts for USANA Health Sciences to reach by the end of the year is $57.00, which would imply a potential downside of approximately -5.06 percent from the previous closing price if it were to be achieved. This prediction is based on a high estimate of $90.00 and a low estimate of $53.00. Even if you are not interested in USNA stock, you should be aware of its competitors and their current standings.

$57.00

-5.06% Downside

Hold
Hold

USANA Health Sciences Fair Value Forecast for 2023 - 2025 - 2030

In the last three years, USANA Health Sciences's Price has grown by 16.09%, rising from $84.00 to $97.52. In the next year, 0 analysts estimate that USANA Health Sciences's Fair Value will decrease by 3.46%, reaching $94.15. According to professional forecasts, in 2030, USANA Health Sciences's Fair Value will decrease by 7.01%, reaching $90.68.

2023 Fair Value Forecast
$94.15
2024 Fair Value Forecast
$86.68
2025 Fair Value Forecast
$88.95
2026 Fair Value Forecast
$91.81
2027 Fair Value Forecast
$92.71
2028 Fair Value Forecast
$90.66
2029 Fair Value Forecast
$90.11
2030 Fair Value Forecast
$90.68
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
WMT Stock Forecast Walmart Outperform 14
$141.71 Buy/Sell $168.96 13.61%
NESN Stock Forecast Nestlé Outperform 5
CHF111.10 Buy/Sell CHF122.48 8.01%
CVS Stock Forecast CVS Health Corp Outperform 13
$85.77 Buy/Sell $115.94 34.72%
PRGO Stock Forecast Perrigo Buy 16
$37.20 Buy/Sell $47.75 27.69%
SMPL Stock Forecast The Simply Good Foods Outperform 15
$36.05 Buy/Sell $40.58 24.83%

USANA Health Sciences Revenue Forecast for 2023 - 2025 - 2030

In the last three years, USANA Health Sciences's Revenue has gone down from $1.19B to $1.19B – a 0.23% drop. For next year, analysts predict Revenue of $1.19B, which would mean an increase of 0.41%. According to professional forecasts, in 2030, USANA Health Sciences's Revenue will decrease by 2.55%, reaching $1.16B.

2023 Rev Forecast
$1.19B
2024 Rev Forecast
$1.15B
2025 Rev Forecast
$1.14B
2026 Rev Forecast
$1.16B
2027 Rev Forecast
$1.17B
2028 Rev Forecast
$1.16B
2029 Rev Forecast
$1.16B
2030 Rev Forecast
$1.16B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
NUS Stock Forecast Nu Skin Enterprises Outperform 18
$44.23 Buy/Sell $51.60 10.78%
HAIN Stock Forecast The Hain Celestial Group Outperform 14
$21.58 Buy/Sell $36.31 57.55%
MED Stock Forecast Medifast Buy 18
$108.71 Buy/Sell $327.33 217.36%

USANA Health Sciences Dividend per Share Forecast for 2023 - 2025 - 2030

Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
HLF Stock Forecast Herbalife Nutrition Buy 16
$16.62 Buy/Sell $37.00 131.65%
TUP Stock Forecast Tupperware Brands Outperform 18
$4.44 Buy/Sell $14.63 170.27%
PETS Stock Forecast PetMed Express Hold 16
$22.07 Buy/Sell $27.00 -9.38%

USANA Health Sciences Free Cash Flow Forecast for 2023 - 2025 - 2030

USANA Health Sciences's Free Cash Flow has grown In the last three years, rising from $140.69M to $123.50T – a growth of 87779404.52%. 0 analysts predict USANA Health Sciences's Free Cash Flow will decrease by 32.16% in the next year, reaching $83.78T. By 2030, professionals predict that USANA Health Sciences's Free Cash Flow will decrease by 42.03%, to $71.59T.

2023 FCF Forecast
$83780.35B
2024 FCF Forecast
$62338.17B
2025 FCF Forecast
$58558.40B
2026 FCF Forecast
$75786.28B
2027 FCF Forecast
$80363.77B
2028 FCF Forecast
$74475.78B
2029 FCF Forecast
$69381.64B
2030 FCF Forecast
$71590.29B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
NATR Stock Forecast Nature's Sunshine Products Buy 16
$9.72 Buy/Sell $24.00 152.06%
FARM Stock Forecast Farmer Bros. Outperform 11
$4.95 Buy/Sell $7.00 152.53%
LWAY Stock Forecast Lifeway Foods - 10
$5.62 Buy/Sell $7.25 -88.08%

USANA Health Sciences Net Income Forecast for 2023 - 2025 - 2030

In the last three years, USANA Health Sciences's Net Income has decreased from $126.22M to $116.51M – a 7.69% drop. In the next year, analysts believe that Net Income will reach $121.63M – an increase of 4.40%. For the next eight years, the forecast is for Net Income to grow by 1.15%.

2023 NI Forecast
$0.12B
2024 NI Forecast
$0.11B
2025 NI Forecast
$0.12B
2026 NI Forecast
$0.12B
2027 NI Forecast
$0.12B
2028 NI Forecast
$0.12B
2029 NI Forecast
$0.12B
2030 NI Forecast
$0.12B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
NHTC Stock Forecast Natural Health Trends - 0
$6.74 Buy/Sell $0.00 255.93%
NAII Stock Forecast Natural Alternatives Internati... - 0
$9.90 Buy/Sell $0.00 1511.01%
LFVN Stock Forecast LifeVantage Hold 0
$6.19 Buy/Sell $7.50 -7.11%

USANA Health Sciences EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, USANA Health Sciences's EBITDA has decreased from $205.20M to $192.89M – a 6.00% drop. In the next year, analysts believe that EBITDA will reach $199.79M – an increase of 3.58%. In 2030, the professionals' prediction is that USNA's EBITDA will decrease by 1.60%, reaching $189.80M.

2023 EBITDA Forecast
$0.20B
2024 EBITDA Forecast
$0.19B
2025 EBITDA Forecast
$0.19B
2026 EBITDA Forecast
$0.19B
2027 EBITDA Forecast
$0.19B
2028 EBITDA Forecast
$0.19B
2029 EBITDA Forecast
$0.19B
2030 EBITDA Forecast
$0.19B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
MTEX Stock Forecast Mannatech - 12
$35.15 Buy/Sell $200.00 11.01%
RELV Stock Forecast Reliv' International - 0
$4.00 Buy/Sell $0.00 -18.50%
MSLP Stock Forecast MusclePharm - 0
$0.15 Buy/Sell $1.65 13.33%

USANA Health Sciences EBIT Forecast for 2023 - 2025 - 2030

USANA Health Sciences's EBIT has decreased by 9.64% In the last three years, from $188.35M to $170.19M. For the next year, analysts predict that EBIT will reach $178.91M – an increase of 5.12%. Over the next eight years, experts believe that USANA Health Sciences's EBIT will grow at a rate of 0.66%.

2023 EBIT Forecast
$0.18B
2024 EBIT Forecast
$0.17B
2025 EBIT Forecast
$0.17B
2026 EBIT Forecast
$0.17B
2027 EBIT Forecast
$0.17B
2028 EBIT Forecast
$0.17B
2029 EBIT Forecast
$0.17B
2030 EBIT Forecast
$0.17B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
YGYI Stock Forecast Youngevity International - 0
$0.13 Buy/Sell $6.00 7.69%
UMHL Stock Forecast Umatrin Holding - 0
$0.02 Buy/Sell $0.00 -100.00%
WW Stock Forecast WW International Outperform 16
$6.34 Buy/Sell $9.24 26.18%

USANA Health Sciences EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last three years, USANA Health Sciences's EPS has grown by 16.09%, rising from $5.16 to $5.99. In the next year, 0 analysts estimate that USANA Health Sciences's EPS will decrease by 3.46%, reaching $5.78. According to professional forecasts, in 2030, USANA Health Sciences's EPS will decrease by 7.01%, reaching $5.57.

2023 EPS Forecast
$5.78
2024 EPS Forecast
$5.32
2025 EPS Forecast
$5.46
2026 EPS Forecast
$5.64
2027 EPS Forecast
$5.69
2028 EPS Forecast
$5.57
2029 EPS Forecast
$5.53
2030 EPS Forecast
$5.57